Positron emission tomographic studies in restless legs syndrome

Claudia Trenkwalder, Artnur S. Walters, Wayne A. Hening, Sudhansu Chokroverty, Angelo Antonini, Vijay Dhawan, David Eidelberg

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

We studied six restless legs syndrome (RLS) patients with [F18]fluorodeoxyglucose (FDG) positron emission tomography (PET). We also studied four of these same patients with [F18]fluorodopa (FDOPA) PET. The patients' FDG and FDOPA PET scans were compared with those from age-matched healthy control subjects. No significant differences between the two groups were found for any regional blood flow values derived from the FDG scans or for any binding constants derived from the FDOPA scans. These results suggest that any abnormal resting brain metabolic activity or putative presynaptic dopaminergic defect in RLS is likely either to be so subtle that it is below the threshold for ready detection by PET or that it is located in an area of neural tissue inaccessible to the current scanner. No substantial defect is likely to involve the dopaminergic nigrostriatal axis.

Original languageEnglish
Pages (from-to)141-145
Number of pages5
JournalMovement Disorders
Volume14
Issue number1
DOIs
Publication statusPublished - 1999

Fingerprint

Restless Legs Syndrome
Positron-Emission Tomography
Electrons
Fluorodeoxyglucose F18
Regional Blood Flow
Healthy Volunteers
Brain
fluorodopa F 18

Keywords

  • Fluorodeoxyglucose
  • Fluorodopa
  • Periodic limb movements (PLM)
  • Positron emission tomography (PET)
  • Restless legs syndrome (RLS)
  • Sleep disorders

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Trenkwalder, C., Walters, A. S., Hening, W. A., Chokroverty, S., Antonini, A., Dhawan, V., & Eidelberg, D. (1999). Positron emission tomographic studies in restless legs syndrome. Movement Disorders, 14(1), 141-145. https://doi.org/10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B

Positron emission tomographic studies in restless legs syndrome. / Trenkwalder, Claudia; Walters, Artnur S.; Hening, Wayne A.; Chokroverty, Sudhansu; Antonini, Angelo; Dhawan, Vijay; Eidelberg, David.

In: Movement Disorders, Vol. 14, No. 1, 1999, p. 141-145.

Research output: Contribution to journalArticle

Trenkwalder, C, Walters, AS, Hening, WA, Chokroverty, S, Antonini, A, Dhawan, V & Eidelberg, D 1999, 'Positron emission tomographic studies in restless legs syndrome', Movement Disorders, vol. 14, no. 1, pp. 141-145. https://doi.org/10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B
Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Antonini A, Dhawan V et al. Positron emission tomographic studies in restless legs syndrome. Movement Disorders. 1999;14(1):141-145. https://doi.org/10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B
Trenkwalder, Claudia ; Walters, Artnur S. ; Hening, Wayne A. ; Chokroverty, Sudhansu ; Antonini, Angelo ; Dhawan, Vijay ; Eidelberg, David. / Positron emission tomographic studies in restless legs syndrome. In: Movement Disorders. 1999 ; Vol. 14, No. 1. pp. 141-145.
@article{6ab0a092e9614beda32b3f625b662a20,
title = "Positron emission tomographic studies in restless legs syndrome",
abstract = "We studied six restless legs syndrome (RLS) patients with [F18]fluorodeoxyglucose (FDG) positron emission tomography (PET). We also studied four of these same patients with [F18]fluorodopa (FDOPA) PET. The patients' FDG and FDOPA PET scans were compared with those from age-matched healthy control subjects. No significant differences between the two groups were found for any regional blood flow values derived from the FDG scans or for any binding constants derived from the FDOPA scans. These results suggest that any abnormal resting brain metabolic activity or putative presynaptic dopaminergic defect in RLS is likely either to be so subtle that it is below the threshold for ready detection by PET or that it is located in an area of neural tissue inaccessible to the current scanner. No substantial defect is likely to involve the dopaminergic nigrostriatal axis.",
keywords = "Fluorodeoxyglucose, Fluorodopa, Periodic limb movements (PLM), Positron emission tomography (PET), Restless legs syndrome (RLS), Sleep disorders",
author = "Claudia Trenkwalder and Walters, {Artnur S.} and Hening, {Wayne A.} and Sudhansu Chokroverty and Angelo Antonini and Vijay Dhawan and David Eidelberg",
year = "1999",
doi = "10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B",
language = "English",
volume = "14",
pages = "141--145",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Positron emission tomographic studies in restless legs syndrome

AU - Trenkwalder, Claudia

AU - Walters, Artnur S.

AU - Hening, Wayne A.

AU - Chokroverty, Sudhansu

AU - Antonini, Angelo

AU - Dhawan, Vijay

AU - Eidelberg, David

PY - 1999

Y1 - 1999

N2 - We studied six restless legs syndrome (RLS) patients with [F18]fluorodeoxyglucose (FDG) positron emission tomography (PET). We also studied four of these same patients with [F18]fluorodopa (FDOPA) PET. The patients' FDG and FDOPA PET scans were compared with those from age-matched healthy control subjects. No significant differences between the two groups were found for any regional blood flow values derived from the FDG scans or for any binding constants derived from the FDOPA scans. These results suggest that any abnormal resting brain metabolic activity or putative presynaptic dopaminergic defect in RLS is likely either to be so subtle that it is below the threshold for ready detection by PET or that it is located in an area of neural tissue inaccessible to the current scanner. No substantial defect is likely to involve the dopaminergic nigrostriatal axis.

AB - We studied six restless legs syndrome (RLS) patients with [F18]fluorodeoxyglucose (FDG) positron emission tomography (PET). We also studied four of these same patients with [F18]fluorodopa (FDOPA) PET. The patients' FDG and FDOPA PET scans were compared with those from age-matched healthy control subjects. No significant differences between the two groups were found for any regional blood flow values derived from the FDG scans or for any binding constants derived from the FDOPA scans. These results suggest that any abnormal resting brain metabolic activity or putative presynaptic dopaminergic defect in RLS is likely either to be so subtle that it is below the threshold for ready detection by PET or that it is located in an area of neural tissue inaccessible to the current scanner. No substantial defect is likely to involve the dopaminergic nigrostriatal axis.

KW - Fluorodeoxyglucose

KW - Fluorodopa

KW - Periodic limb movements (PLM)

KW - Positron emission tomography (PET)

KW - Restless legs syndrome (RLS)

KW - Sleep disorders

UR - http://www.scopus.com/inward/record.url?scp=0032935438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032935438&partnerID=8YFLogxK

U2 - 10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B

DO - 10.1002/1531-8257(199901)14:1<141::AID-MDS1024>3.0.CO;2-B

M3 - Article

VL - 14

SP - 141

EP - 145

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 1

ER -